Floatz logo

IBUPROFEN

Cervicobrachial Neuralgia

Universidad Europea de MadridSmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Cervicobrachial Neuralgia cohort.

Asset / SponsorPhaseRating
Botulinum Toxin Serotype A
University of California, Los Angeles
Phase 4BB
DEXAMETHASONE
Assistance Publique - Hôpitaux de Paris
Phase 3B
LIDOCAINE
Centre Hospitalier Universitaire Saint Pierre
N/AD

Same molecule, other indications

IBUPROFEN is also rated in:

chronic pain syndromeDormant
BBB
Indicative ·
72 / 100
View asset →
migraine disorderDormant
BBB
Indicative ·
72 / 100
View asset →
relapsing-remitting multiple sclerosisDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →